Scholar Rock Holding Corp (SRRK)

Scholar Rock Holding Corp (SRRK) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $5.1B; returns 1 day -1.1%, 1 week +4.0%, 1 year +44.8%.

Scholar Rock Holding Corp. is a late-stage, pre-commercial biopharmaceutical company focused on developing novel monoclonal antibodies that selectively target protein growth factors to treat serious neuromuscular and cardiometabolic diseases.

Groups SRRK belongs to

• Biotechnology
• Biopharmaceutical
• Clinical Stage Biopharma
• Monoclonal Antibodies
• Healthcare
• Clinical Stage
• Rare Diseases
• Metabolic Disorders
• Oncology
• Life Sciences
• R&D

SRRK financial model: income statement, cash flow and balance sheet